BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 7597046)

  • 1. Decreased brain reward produced by ethanol withdrawal.
    Schulteis G; Markou A; Cole M; Koob GF
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5880-4. PubMed ID: 7597046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescent intermittent ethanol exposure diminishes anhedonia during ethanol withdrawal in adulthood.
    Boutros N; Semenova S; Markou A
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):856-64. PubMed ID: 24560005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain reward deficits accompany withdrawal (hangover) from acute ethanol in rats.
    Schulteis G; Liu J
    Alcohol; 2006 May; 39(1):21-8. PubMed ID: 16938626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.
    Lin D; Koob GF; Markou A
    Psychopharmacology (Berl); 1999 Aug; 145(3):283-94. PubMed ID: 10494577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake.
    Holtz NA; Radke AK; Zlebnik NE; Harris AC; Carroll ME
    Brain Res; 2015 Mar; 1602():119-26. PubMed ID: 25582876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.
    Rylkova D; Boissoneault J; Isaac S; Prado M; Shah HP; Bruijnzeel AW
    Neuropeptides; 2008 Jun; 42(3):215-27. PubMed ID: 18468678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased reward during acute alcohol withdrawal in rats selectively bred for low alcohol drinking.
    Chester JA; Rausch EJ; June HL; Froehlich JC
    Alcohol; 2006 Apr; 38(3):165-72. PubMed ID: 16905442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies.
    Johnson PM; Hollander JA; Kenny PJ
    Pharmacol Biochem Behav; 2008 Sep; 90(3):409-15. PubMed ID: 18466962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditioned withdrawal drives heroin consumption and decreases reward sensitivity.
    Kenny PJ; Chen SA; Kitamura O; Markou A; Koob GF
    J Neurosci; 2006 May; 26(22):5894-900. PubMed ID: 16738231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
    Cryan JF; Bruijnzeel AW; Skjei KL; Markou A
    Psychopharmacology (Berl); 2003 Jul; 168(3):347-58. PubMed ID: 12698231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
    Paterson NE; Balfour DJ; Markou A
    Nicotine Tob Res; 2008 Jun; 10(6):995-1008. PubMed ID: 18584463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
    Bruijnzeel AW; Zislis G; Wilson C; Gold MS
    Neuropsychopharmacology; 2007 Apr; 32(4):955-63. PubMed ID: 16943772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems.
    Kenny PJ; Markou A
    J Neurosci; 2005 Jun; 25(26):6208-12. PubMed ID: 15987950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postcocaine anhedonia. An animal model of cocaine withdrawal.
    Markou A; Koob GF
    Neuropsychopharmacology; 1991 Jan; 4(1):17-26. PubMed ID: 2003866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats.
    Liu J; Pan H; Gold MS; Derendorf H; Bruijnzeel AW
    Neuropharmacology; 2008 Oct; 55(5):812-8. PubMed ID: 18634811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats.
    Markou A; Harrison AA; Chevrette J; Hoyer D
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):133-42. PubMed ID: 15452682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats.
    Bruijnzeel AW; Markou A
    Brain Res; 2005 Oct; 1058(1-2):91-100. PubMed ID: 16126181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats.
    Qi X; Guzhva L; Ji Y; Bruijnzeel AW
    Behav Brain Res; 2015 Oct; 292():259-65. PubMed ID: 26112757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats.
    Paterson NE; Myers C; Markou A
    Psychopharmacology (Berl); 2000 Nov; 152(4):440-6. PubMed ID: 11140337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.
    Yamada H; Bishnoi M; Keijzers KF; van Tuijl IA; Small E; Shah HP; Bauzo RM; Kobeissy FH; Sabarinath SN; Derendorf H; Bruijnzeel AW
    Pharmacol Biochem Behav; 2010 Jun; 95(4):401-9. PubMed ID: 20211642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.